EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy

Linlin Sun, Miao Ding, Fuhua Chen, Dingyu Zhu, Xinmiao Xie

PeerJ · 2023

DOI: 10.7717/peerj.14826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Linlin Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Podocytes, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai, Shanghai Municipal Health Bureau Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Podocyte injury is a critical factor in the pathogenesis of diabeticnephropathy (DN). Emerging evidence has demonstrated that breviscapine (Bre) exerts a renoprotective effect on diabetic rats. However, the effects of Bre on regulating podocyte injury under high glucose (HG) conditions remain unclear. In this study, an experimental mouse model of DN was induced by intraperitoneal injections of streptozotocin (STZ) in vivo . The effects of Bre on podocyte injury were assessed using cell counting kit-8 (CCK-8) assay, TdT-mediated dUTPnick-endlabelling (TUNEL) staining, quantitative real-time PCR (qRT‒PCR) and western blot analysis. We found that renal function was significantly decreased in diabetic mice, and this effect was blocked by Bre treatment. Bre effectively increased podocyte viability and inhibited HG-induced cell apoptosis. Furthermore, Bre ameliorated HG-induced podocyte injury, as evidenced by decreased α-smooth muscle actin (α-SMA) expression and increased podocin and synaptopodin expression. Mechanistically, Bre inhibited HG-induced nuclear factorkappaB (NF-κB) signalling activation and subsequently decreased NLR family pyrin domain containing 3 (NLRP3) inflammasome activation, resulting in a decrease in pyroptosis. Pharmacological inhibition of NLRP3 decreased HG-induced podocyte injury, whereas the NLRP3 agonist abrogated the effects of Bre on inhibiting podocyte injury. In summary, these results demonstrate that Bre alleviates HG-induced podocyte injury and improves renal function in diabetic mice, at least in part by inhibiting NF-κB/NLRP3-mediated pyroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesPodocytesDiabetes Mellitus, ExperimentalRatsMiceAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BPyroptosisFlavonoids

Stichwörter der Autor:innen

BreviscapineDiabetic nephropathyNLRP3PodocytePyroptosis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BbreviscapineFlavonoidsNlrp3 protein, mouseNlrp3 protein, rat

Autor:innen und Institutionen

  • Department of Nephrology, Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Förderung

  • Natural Science Foundation of Shanghai
  • Shanghai Municipal Health Bureau Project

Zitieren

APA

Sun, L., Ding, M., Chen, F., Zhu, D., & Xie, X. (2023). Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy. PeerJ. https://doi.org/10.7717/peerj.14826

Vancouver

Sun L, Ding M, Chen F, Zhu D, Xie X. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy. PeerJ. 2023. doi:10.7717/peerj.14826

BibTeX
@article{Sun2023,
  author = {Sun, Linlin and Ding, Miao and Chen, Fuhua and Zhu, Dingyu and Xie, Xinmiao},
  title = {Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.14826}
}
Kostenlos starten →